Equillium Inc to Discuss the Acquisition of Bioniz Therapeutics - M&A Call Transcript
Welcome and thank you for joining us this morning for Equillium's announcement of the acquisition of Bioniz Therapeutics. Presenting from the company this morning are Mr. Bruce Steel, Chief Executive Officer of Equillium, and Dr. Stephen Connelly, Chief Scientific Officer of Equillium; Mr. Jason Keyes, Chief Financial Officer; and Dr. Matt Ritter, Vice President of Corporate Development, will also join for the Q&A following the presentation.
Before we begin I would like to remind you that any statements made during this call that are not historical are considered to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Actual results may differ materially from those indicated by these statements as a result of various important factors. This includes those discussed in the Risk Factors section in the company's most recent annual report on Form 10-K as well as other reports filed with the SEC.
I'll remind you that this call is being recorded and the replay will be available on the company's website following the conclusion
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |